Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cantor Fitzgerald
UBS
Farmers Insurance
Johnson and Johnson
Queensland Health

Generated: March 21, 2019

DrugPatentWatch Database Preview

Istituto Bio Ita Spa Company Profile

« Back to Dashboard

What is the competitive landscape for ISTITUTO BIO ITA SPA, and what generic and branded alternatives to ISTITUTO BIO ITA SPA drugs are available?

ISTITUTO BIO ITA SPA has thirteen approved drugs.



Summary for Istituto Bio Ita Spa
US Patents:0
Tradenames:7
Ingredients:7
NDAs:13

Drugs and US Patents for Istituto Bio Ita Spa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Istituto Bio Ita Spa PIPERACILLIN piperacillin sodium INJECTABLE;INJECTION 065157-001 Jul 12, 2004 RX No Yes ➤ Sign Up ➤ Sign Up
Istituto Bio Ita Spa PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 065523-003 May 31, 2011 AP RX No No ➤ Sign Up ➤ Sign Up
Istituto Bio Ita Spa AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062797-002 Jul 12, 1993 AP RX No No ➤ Sign Up ➤ Sign Up
Istituto Bio Ita Spa PIPERACILLIN piperacillin sodium INJECTABLE;INJECTION 065114-003 Nov 14, 2003 RX No Yes ➤ Sign Up ➤ Sign Up
Istituto Bio Ita Spa AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062797-001 Jul 12, 1993 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Chubb
Merck
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.